Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study

Translated title of the contribution: Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study

L.V. Beerepoot, P.O. Witteveen, G. Groenewegen, W.E. Fogler, B.K. Sim, C. Sidor, B.A. Zonnenberg, F.M. Schramel, M.F.B.G. Gebbink, E.E. Voest

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionRecombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study
Original languageUndefined/Unknown
Pages (from-to)4025-4033
Number of pages9
JournalClinical Cancer Research
Volume9
Issue number11
Publication statusPublished - 2003

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde(GENK)
  • Bescherming en bevordering van de menselijke gezondheid
  • Other medical specialities

Cite this